acc_aha指南_不稳定型心绞痛和非st段抬高型心肌梗死

上传人:tian****1990 文档编号:80906188 上传时间:2019-02-20 格式:PPT 页数:63 大小:896KB
返回 下载 相关 举报
acc_aha指南_不稳定型心绞痛和非st段抬高型心肌梗死_第1页
第1页 / 共63页
acc_aha指南_不稳定型心绞痛和非st段抬高型心肌梗死_第2页
第2页 / 共63页
acc_aha指南_不稳定型心绞痛和非st段抬高型心肌梗死_第3页
第3页 / 共63页
acc_aha指南_不稳定型心绞痛和非st段抬高型心肌梗死_第4页
第4页 / 共63页
acc_aha指南_不稳定型心绞痛和非st段抬高型心肌梗死_第5页
第5页 / 共63页
点击查看更多>>
资源描述

《acc_aha指南_不稳定型心绞痛和非st段抬高型心肌梗死》由会员分享,可在线阅读,更多相关《acc_aha指南_不稳定型心绞痛和非st段抬高型心肌梗死(63页珍藏版)》请在金锄头文库上搜索。

1、ACC/AHA GUIDELINES: UNSTABLE ANGINA & NONST-SEGMENT ELEVATION MYOCARDIAL INFARCTION,王宗倫 醫師 講述引用 Wang, Tzong-Luen,MD, PhD, FACC, FESC,UNSTABLE ANGINA & NONST-SEGMENT ELEVATION MYOCARDIAL INFARCTION COMMITTEE MEMBERS,Elliott M. Antman, MD John W. Beasley, MD Robert M. Califf, MD Melvin D. Cheitlin, MD

2、 Judith S. Hochman, MD Robert H. Jones, MD Dean Kereiakes, MD,Joel Kupersmith, MD Thomas N. Levin, MD Carl J. Pepine, MD John W. Schaeffer, MD Earl E. Smith, III, MD David E. Steward, MD Pierre Theroux, MD,Eugene Braunwald, MD, Chair,ACC/AHA GUIDELINES,ACUTE CORONARY SYNDROME,No ST Elevation,ST Elev

3、ation,Unstable Angina,NQMI QwMI Myocardial Infarction,NSTEMI,不穩定性心絞痛及非ST升高心肌梗塞原因,Thrombosis,Thrombosis,Mechanical Obstruction,Mechanical Obstruction,Dynamic Obstruction,Dynamic Obstruction,Inflammation/ Infection,Inflammation/ Infection, MVO2, MVO2,Braunwald, Circulation 98:2219, 1998,.,.,不穩定性心絞痛及非S

4、T升高心肌梗塞 三種主要表現,Rest Angina* Angina occurring at rest and prolonged, usually 20 minutes New-onset Angina New-onset angina of at least CCS Class III severity Increasing Angina Previously diagnosed angina that has become distinctly more frequent, longer in duration, or lower in threshold (i.e., increas

5、ed by 1 CCS) class to at least CCS Class III severity.,Braunwald Circulation 80:410; 1989,* Pts with NSTEMI usually present with angina at rest.,Changes in Focus on Heart Failure,TROPONIN I濃度預測不穩定性心絞痛及非ST升高心肌梗塞原因死亡的危險,1.0,1.7,3.4,3.7,6.0,7.5,0,2,4,6,8,0 to 0.4,0.4 to 1.0,1.0 to 2.0,2.0 to 5.0,5.0 to

6、 9.0,9.0,831,174,148,134,67,50,Cardiac Troponin I (ng/ml) Risk Ratio 1.0 1.8 3.5 3.9 6.2 7.8 Antman N Engl J Med. 335:1342, 1996,Mortality at 42 Days (% of patients),N Engl J Med. 339:436-43, 1998,PURSUIT TRIAL: 死亡或心肌梗塞,Prob of Event-Free Survival,Days,1,0.98,0.96,0.94,0.92,0,0.9,0.88,0.86,0.84,0.82

7、,0.8,30,60,90,120,150,180,2.0,6.4,3.3,1.7,6.9,5.0,0,1,2,3,4,5,6,7,1993,1057,RR,1641,792,RR,Total Mortality,Cardiac Mortality,6,PTS,7,No. Trials,Trop.,Neg Pos,Neg Pos,TROPONINS T 及 I 作為死亡率的預測指標,建議,Class I 1. Patients with suspected ACS with chest discomfort at rest for 20 min, hemodynamic instability

8、, or recent syncope or presyncope should be referred immediately to an ED or a specialized chest pain unit. Other patients with a suspected ACS may be seen initially in an ED, a chest pain unit, or an outpatient facility.,危險評估,Class I 1. Noninvasive stress testing in low-risk pts free of ischemia at

9、 rest or with low-level activity and of CHF for a minimum of 12 to 24 h. 2. Noninvasive stress testing in pts at intermediate risk who have been free of ischemia at rest or with low-level activity and of CHF for a minimum of 2 or 3 days.,危險評估,Class I 3. Choice of stress test is based on the resting

10、ECG, local expertise, and technologies. Treadmill exercise in pts able to exercise in whom the ECG is free of baseline ST-segment abnormalities, BBB, LVH, intraventricular conduction defect, paced rhythm, pre-excitation, and digoxin effect. 4. An imaging modality in pts with resting ST-segment depre

11、ssion (0.1 mV), LVH, BBB, IVCD, pre-excitation, or digoxin who are able to exercise.,危險評估,5. Pharmacological stress testing with imaging when physical limitations (e.g., arthritis, amputation, severe peripheral vascular disease, severe COPD, general debility) preclude adequate exercise stress. 6. Pr

12、ompt angiography without noninvasive risk stratification for failure of stabilization with medical treatment.,Class I,非侵襲性危險評估,1. Severe LV dysfunction (LVEF 0.35), rest or exercise 2. High-risk treadmill score (score -11) 3. Stress-induced large perfusion defect 4. Stress-induced multiple perfusion

13、 defects,High risk (3% annual mortality rate),Gibbons et al JACC 33:2092, 1999,非侵襲性危險評估,5. Large, fixed perfusion defect with LV dilation or increased lung uptake 6. Stress-induced moderate perfusion defect with LV dilation or increased lung uptake 7. Echocardiographic wall motion abnormality (2 seg

14、ments) at a low dose of dobutamine ( 10 mgkg-1 min-1) or at a low heart rate (120 bpm),High risk (3% annual mortality rate),Gibbons et al JACC 33:2092, 1999,1. Mild/moderate resting LV dysfunction (LVEF 0.35-0.49) 2. Intermediate-risk treadmill score (-11 score 5) 3. Stress-induced moderate perfusio

15、n defect without LV dilation or increased lung intake 4. Echocardiographic ischemia with wall motion abnormality involving 2 segments only at higher doses of dobutamine,Intermediate Risk (1-3% annual mortality rate),非侵襲性危險評估,Gibbons et al JACC 33:2092, 1999,非侵襲性危險評估,1. Low-risk treadmill score (score 5) 2. Normal perfusion or small myocardial perfusion defect at rest or with stress 3. Normal echocardiographic wall motion or no change of limited resting wall motion abnormalities during stress,Low Risk (1% annual mortality rate),Gibbons et al JACC 33:2092, 1999,非侵襲性危險評估,Duke Tr

展开阅读全文
相关资源
相关搜索

当前位置:首页 > 高等教育 > 大学课件

电脑版 |金锄头文库版权所有
经营许可证:蜀ICP备13022795号 | 川公网安备 51140202000112号